æéšç§åŠçåäžã®ç§åŠæè¡æ¯èæ©æ§(JST)ã®çµå¶äŒç»éšãšããã³ã¹åæå®€ã¯2022幎3æ31æ¥ã«ããããããŒããŒããã¿ãæ°åã³ããç ç©¶ããšããé¡ç®ã®å°ååãã·ã°ããšããã³ã¹ãã®åçãåºçããã
ãé¢é£èšäºã
â JSTãæ°åã³ããç ç©¶ã®ç§åŠè«æã®åååæçµæãååãšããŠçºè¡
åååã®ç¬¬4ç« ã§ã¯ãJSTãæšé²ããŠãããCOVID-19(æ°åã³ãããŠã€ã«ã¹ææç)ãžã®å¯Ÿå¿ã«åãããã©ã³Bç ç©¶ãäºæ¥ããŸãšããŠè§£èª¬ããŠããã
åœæãJSTçäºé·ã ã£ã濱å£éææ°â»1ã¯ãCOVID-19ã«å¯Ÿããç ç©¶éçºã®æ¬åœã«ãªãããã©ã³Aãã¯ã¯ã¯ãã³ãšæ²»çè¬ã®éçºãšäºæ¥åãšããå»çåéã§ã®ç ç©¶éçºã«ãªããšãããã©ã³BãšããŠããå¶éç¡ãç§»åãã§ããèªç±ã«äººãšäŒããã»éãããçµæžæŽ»åãã§ãã瀟äŒãå®çŸãããç ç©¶ãæå±ããã
ãã©ã³Bã§ã¯ããèŠã€ããããæž ããããè·ããã®3ã€ã®ããŒãã§ãJSTã®ç ç©¶éçºãããžã§ã¯ããšããŠç ç©¶éçºãããžã§ã¯ããåéãããã®äžããåªããç ç©¶ãéžã³ãç ç©¶éçºè²»ãæäŸããå®çšåãå³ã£ãŠããã
ãã©ã³Bã®COVID-19ããèŠã€ãããç ç©¶éçºããŒãã§ã¯ãããã©ãããã¯çµæ¶ã·ãŒããçšããé«æåºŠãŠã€ã«ã¹æ€åºæè¡ãããäœäŸµè¥²ãã€ã¹ã«ãŒãããã»å æ¿çž®ã·ã¹ãã ãããããžã¿ã«ãŠã€ã«ã¹æ€åºæ³ããšãã£ãç ç©¶éçºãããžã§ã¯ããé²ããŠããæäžã ã
ãšããã³ã¹åæå®€ã¯ããããããèŠã€ãããç ç©¶éçºã»äºæ¥åããŒãã®åºç€ãšãªã£ãäžçäžã®ç ç©¶éçºè«æããã¯ã©ãªãã€ãã»ã¢ããªãã£ã¯ã¹ç€Ÿ(æ¬ç€Ÿã¯ç±³åœãã£ã©ãã«ãã£ã¢åžãæ¥æ¬ãªãã£ã¹ã¯æ±äº¬éœæž¯åº)ãçºè¡ããŠããããããããŒããŒããåæãããã®è«æã®äžèº«ã玹ä»ãããªã被åŒçšæ°ãå€ãããåæããŠããã
ãããããŒããŒã¯ãç§åŠæè¡è«æã®äžã§çŽè¿2ã«æéã®è¢«åŒçšæ°ãããã0.1ïŒ ã«å ¥ã£ãŠããæçšã»éèŠãªç§åŠæè¡è«æã§ã2ã«æããšã«å¹Žã«6ååºçã»å ¬éãããŠããã
ã·ã°ããšããã³ã¹ã§ã¯ãèŠã€ããæè¡ã«ã€ããŠããCOVID-19ã®æ žé žå¢æ®æ³ã®RT-PCRæ³ãLAMPæ³ãããæäœæ€åºæ³ããããã€ãªã»ã³ãµãããCRISPR/CASããã廿°Žããã®æ€åºæ³ãããAI(人工ç¥èœ)ã«ãã蚺æããšãã£ã6ããŒãã«ã€ããŠãææ°è«æã®åŸåãåæããŠããããŸã ãŸã æåãªç ç©¶éçºããŒããèŠãã ããå¯èœæ§ããããšããŠããã
2020幎ã®vol.1ãã2021幎ã®vol.3ãŸã§ã«çºè¡ããããããããŒããŒã§ã¯ãæ žé žå¢æ®æ³ã®RT-PCRæ³ãLAMPæ³ã«ã€ããŠã16å ±ã®ç§åŠæè¡è«æã玹ä»ãããŠããã
ãã®äžã§ãç»å Žåæ°ãå€ãç§åŠæè¡è«æãæžããã®ã¯ããã€ãã®ã·ã£ãªãã»ãã«ãªã³å»ç§å€§åŠã®ãªã¢ã«ã¿ã€ã æ žé žå¢å¹ æ³(PCRæ³)ã®ãªã¢ã«ã¿ã€ã RT-PCRæ³(é転åRT-PCRæ³)ã«ã€ããŠã®ç§åŠæè¡è«æã ã£ãã
ãã®ç§åŠæè¡è«æã§ã¯åœæãSARS-CoV-2(æ°åã³ãããŠã€ã«ã¹)ã®æ€åºã«é©çšãããšããéå ±å å®¹ãæžãããŠããããŸã 人ãã人ãžã®ææãæç¢ºã§ã¯ãªãã£ãåæã«ãªã¢ã«ã¿ã€ã RT-PCRæ³ã®é©çšãå ±åããŠããããããŠããã®ãªã¢ã«ã¿ã€ã RT-PCRæ³ãé©çšãã蚺æã¯ãŒã¯ãããŒã®ç¢ºç«ã»æ€èšŒã«ã€ããŠã解説ããŠããã
ã·ã°ããšããã³ã¹ã§ã¯ãRT-PCRæ³ã«ã€ããŠããç±³åœãžã§ã³ãºã»ãããã³ã¹å€§åŠã®ãæŽé²åŸã®æéçµéãšRT-PCRæ³ã«ããåœéœæ§çã®å€åããšãäžåœã®è¯äžç§æå€§åŠã®ãæ°åã³ããã®PCRçµæãšèžéšCTç»åã®çžé¢ããããåŒçšãããè«æãšããŠç»å ŽããŠããããšåæããŠããã
åŸæ¶²æ€äœæ¯èŒã§ã¯ãæ¥æ¬ã®æç¥å»ç§å€§åŠç é¢ã®æ€æ»æ€äœæ¯èŒã解説ããç§åŠæè¡è«æã玹ä»ãããŠãããCOVID-19ã®çºççŽåŸã®æ€äœã§ã¯ãåŸæ¶²æšæ¬ãšéŒ»åœåã¹ã¯ãæšæ¬ã®å®æ§ççµæã¯é¡äŒŒããŠããããå埩æã«ãªããšåŸæ¶²æšæ¬ã®æ¹ãåªããŠããããšã瀺åããçµæãåŸããããšäŒããŠããã
æäœæ€åºæ³ã§ã¯ãéŠæž¯å€§åŠã®ãåã®å¥¥ã®åŸæ¶²ãµã³ãã«ãšè¡æž æäœåå¿ã«ããããŠã€ã«ã¹éã®æéçãããã¡ã€ã«ããšããè«æãããåŒçšããããšã·ã°ããšããã³ã¹å ã§ç޹ä»ãããŠããã
ãŠã€ã«ã¹ã®RNAãã¹ãã€ã¯ã¿ã³ãã¯è³ªãªã©ãæ€åºãããã€ãªã»ã³ãµãããåŒçšãããè«æãšããŠç»å ŽããŠãããã¹ã€ã¹é£éŠå·¥ç§å€§åŠã®ã2å æ©èœãã©ãºã¢ããã¯å ç±ãã€ãªã»ã³ãµããšãéåœã®éåœåºç€ç§åŠç ç©¶æã®ãFETãã€ãªã»ã³ãµããããåŒçšãããå®çšåãé²ãã ããã ã
廿°Žããã®æ€åºã«ã€ããŠã¯ããªãŒã¹ãã©ãªã¢ã®ã¯ã€ãŒã³ãºã©ã³ã倧åŠãå ±åããã廿°Žäžã®æ°åã³ãããŠã€ã«ã¹ãæ¿çž®ããRT-qPCT(é転åé)ããRNAã³ããŒéãç®åºããã¢ã³ãã«ã«ãã·ãã¥ã¬ãŒã·ã§ã³æ³ããã察象ãšãªãæµåã§ã®æ£è æ°ã®äžå€®å€ãæšå®ãããè«æãããåŒçšãããŠãããæ¥æ¬ã§ã¯ãåæµ·é倧åŠã®åå³¶æ£ç« åææã®ç ç©¶ã°ã«ãŒããè¡ã£ãŠãã廿°Žããã®æšå®æ³ã玹ä»ãããŠããã
äžæ¹ã§ããæž ãããç ç©¶éçºããŒãã§ã¯ããããããŒããŒã§ã®ç޹ä»ã¯4å ±ã«çãŸããã¬ãã¥ãŒçãªå 容ã®è«æã«çãŸã£ãŠãããšããã
ãè·ããç ç©¶éçºããŒãã§ã¯ããã¹ã¯ã«ã€ããŠã®è«æãå€ãã£ããšããŠããã
ç±³åœã·ã«ãŽå€§åŠãšã¢ã«ãŽã³ãåœç«ç ç©¶æã¯ããã¹ã¯ã®çŽ æã«ãããŠã€ã«ã¹ã®ãéçãç ç©¶ããŠãããã³ããã³ã·ã«ã¯ãã³ããã³ã·ãã©ã³ãã³ããã³ãã©ã³ãã«ãªã©ã®ãã€ããªããçŽ æã®ãéçã¯ç²ååŸ300nmæªæºã§80ïŒ ä»¥äžãç²ååŸ300nm以äžã§90ïŒ ä»¥äžã ã£ããšå ±åããŠããã
ã·ã°ããšããã³ã¹ã®äžã§ã¯ãç±³ãããªãã»ã¢ãã©ã³ãã£ãã¯å€§åŠã®ããã§ã€ã¹ãã¹ã¯ã®æå¹æ§ãå¯èŠåãããå®éšè£ 眮ã«ã€ããŠè§£èª¬ããŠããããŸããæ³šç®ãéããŠãããšããè±ãªãã¯ã¹ãã©ãŒã倧åŠãåæããSARS-CoV-2ã®æ¥è§Šç®¡çãœãããŠã§ã¢ã®æŽ»çšåºŠåãã®å¹æåæãè峿·±ããšããŠããããã®äžã§ãæ¥æ¬ã§ã®æ¥è§Šç®¡çãœãããŠã§ã¢ã®æŽ»çšæ³ãšæ¯èŒããããšãæ°ããèŠç¹ãèŠãã ãå¯èœæ§ãææããŠããã
çè æ³šé
â»1濱å£éææ°ã¯2022幎3æ31æ¥ãŸã§JSTçäºé·ãåããŠããã2022幎4æ1æ¥ã«æ©æ¬å仿°ãJSTçäºé·ã«å°±ä»»ããŠãããåè:JSTãæ°çäºé·ã«çŸNIMSçäºé·ã®æ©æ¬æ°ã就任ãšå ¬è¡š

